Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy

Ann Surg Oncol. 2022 Mar;29(3):1498-1501. doi: 10.1245/s10434-021-11055-1. Epub 2021 Nov 17.

Beth A Helmink^{1

2}, George Ansstas^{3

2}, Ryan C Fields^{4

5}

¹ Section of Surgical Oncology, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
² Alvin J. Siteman Comprehensive Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
³ Department of Medical Oncology, Washington University School of Medicine, St. Louis, MO, USA.
⁴ Section of Surgical Oncology, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA. rcfields@wustl.edu.
⁵ Alvin J. Siteman Comprehensive Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. rcfields@wustl.edu.

No abstract available

Publication types